Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside...
Whole milk makes a comeback in new MAHA...
Hawley pushes legal action against Meta after whistleblowers...
As Trump’s bawdy birthday message to Jeffrey Epstein...
Elon Musk agrees with JD Vance on the...
Scalise hints GOP may push nationwide crime crackdown...
Harris admits Biden ‘got tired,’ denies ‘conspiracy’ to...
GOP senator compares Israel’s Hamas fight to US...
Trump calls for death penalty for suspect in...
Jury selection still underway in Ryan Routh trial,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Placement to Support Next Phases of Grandis Project

by admin July 25, 2024
July 25, 2024
Placement to Support Next Phases of Grandis Project

Elixir Energy Limited (Elixir or the Company) is pleased to announce that it has received binding commitments for a placement of new shares in the Company (Placement), on the following terms:

1. Placement to raise $6.25 million (before costs) through the issue of 62.5 million new shares to institutional and sophisticated investors at a price of 10 cents per share (a 13% discount to the last close and a 12.7% discount to the 5 day VWAP).

2. Placement participants will receive one (1) one of Elixir’s currently listed options (EXROBs) for every four (4) Placement Shares issued. These already listed EXROB Options have an exercise price of 12 cents and a term expiring on 17 October 2026.

HIGHLIGHTS

Over-subsribed share placement of $6.25 million to institutional and sophisticated investorsFunds to be used to support the next phases of the Grandis Project

The capital raising was strongly supported, with demand in excess of the placement size, and introduced a number of new institutional investors to the Company’s register.

The new capital raised will be deployed in the next phases of the Grandis Project – to deal with potential contingencies that might arise from the imminent multiple stage stimulation and flow testing program at the Company’s Daydream-2 well; and, position the Company for the next phases of Project Grandis – including ordering long lead items for the next well and improving the negotiating position for potential farm-out negotiations post the flow testing phase.

The 62.5 million Placement Shares will be issued under listing rule 7.1 A and the 18,750,000 Listed Options will be issued under listing rule 7.1.

The new shares are anticipated to be issued on Wednesday, 31 July 2024.

Taylor Collison Limited and Originate Capital Pty Ltd acted as Joint Lead Managers to the Placement.

Elixir’s Managing Director, Mr. Neil Young, said: “We are pleased to receive this financial support from existing and new investors to fund the final phases of the Daydream-2 program and take forward Project Grandis into its next phases. Equipment is mobilizing to the well lease and the commencement of work is now imminent.”

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Copper Price Update: Q2 2024 in Review
next post
Adisyn Ltd (ASX: AI1) – Trading Halt

You may also like

IsoEnergy to Acquire Anfield Energy, Strengthening US Uranium...

October 4, 2024

5 US Longevity and Anti-aging Stocks to Watch...

January 24, 2025

Silver47 Identifies Critical Minerals Antimony and Gallium Potential...

February 12, 2025

Yvonne Blaszczyk: Gold, Silver — Last Call to...

September 6, 2024

Potash, Oil and Metal Shipments Halted as Canadian...

August 23, 2024

Progress Update on Hydrogen Supply Chain and Prototype...

December 25, 2024

Cygnus Metals

January 27, 2025

Skyharbour’s Partner North Shore Uranium Signs Exploration Agreement...

March 21, 2025

FY25 Preliminary Results Summary and Company Update

August 29, 2025

Havilah Deals Uranium Assets for Equity Interest in...

October 21, 2024

Recent Posts

  • Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside candids and bizarre animal pics
  • Whole milk makes a comeback in new MAHA children’s health strategy
  • Hawley pushes legal action against Meta after whistleblowers detail child abuse in VR
  • As Trump’s bawdy birthday message to Jeffrey Epstein appears, he still insists he never sent it
  • Elon Musk agrees with JD Vance on the ‘big lie the Democrats told about violent crime’

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (913)
    • Investing (2,932)
    • Politics (3,601)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.